This study evaluated the impact of the transition to in-house performance of serum herpes simplex virus (HSV) PCRs. Transition to in-house performance reduced diagnostic turnaround times and acyclovir durations, improved evaluation integrity, and expedited discharge in infants with negative diagnostics.